Trial Details
RECRUITINGBasic Information
| Clinical ID | c607 |
|---|---|
| Identifier | NCT06332534 |
| Trial Title | Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Upadacitinib |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Oakland |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-08-08 |
|---|---|
| Primary Completion Date | 2031-02 |
| Completion Date | 2034-12 |